Neisseria meningitidis endophthalmitis.
Zacks
David N
DN
Ann Arbor, Michigan, USA.
D000293:Adolescent; D002442:Ceftazidime / Q000627:therapeutic use; D004269:DNA, Bacterial / Q000032:analysis; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D009877:Endophthalmitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008297:Male; D008589:Meningococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D009345:Neisseria meningitidis / Q000235:genetics / Q000302:isolation & purification*; D016133:Polymerase Chain Reaction; D014640:Vancomycin / Q000627:therapeutic use; D014822:Vitreous Body / Q000382:microbiology
D004269:DNA, Bacterial; D014640:Vancomycin; D002442:Ceftazidime